FDA NDC Directory · JSON-LD · Markdown

OXCARBAZEPINE

NDC 70377-117 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerBiocon Pharma Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA218278
Dosage form / routeSUSPENSION · ORAL
Active ingredientsOXCARBAZEPINE (60 mg/mL)
Marketing started20240531
Package count1

External sources

Source: openFDA. Public-domain (CC0).